search
Back to results

Cold Acclimation as a Modulator of Brown Adipose Tissue Function in Adults With Obesity (MOTORBAT)

Primary Purpose

Obesity

Status
Recruiting
Phase
Not Applicable
Locations
Finland
Study Type
Interventional
Intervention
Cold acclimation
Intervention Control group - volunteers with obesity
Acute cold exposure
Sponsored by
Turku University Hospital
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Obesity

Eligibility Criteria

18 Years - 45 Years (Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • BMI>30kg/m2 (for participants with obesity)
  • BMI<25kg/m2 (for lean participants)
  • Waist circumference >94 cm for men (for participants with obesity)
  • Waist circumference > 80 for women (for participants with obesity)
  • Glucose ≥7.8 and <11 mmol/L after OGTT (for participants with obesity)

Exclusion Criteria:

  • Being regularly exposed to cold environments for the last 3 months (e.g. having a job as a ski monitor, fishmonger, woodcutter, etc.; or doing sports/leisure activities outdoors for prolonged periods of time, etc.)
  • Having gone for winter/ice swimming and bathing more than once every 2 weeks during the last 3 months.
  • Inability to undergo scanning (e.g., claustrophobia)
  • Pregnancy
  • Smoking (or use of nicotine based products)
  • Hypo/hyperthyroidism
  • Malignancies
  • Immune disorders
  • Viral or bacterial infections
  • Abnormal cardiovascular status, arrhythmia and/or long QTc in ECG, abnormal cardiac murmur, previous history of cardiovascular disease
  • Allergy to lidocaine or epinephrine, or other local anaesthetics
  • Weight change (intentional or not) over the last 6-months > than 5% of body weight
  • Any other cardiovascular, pulmonary, orthopaedic, neurologic, psychiatric or other conditions that in the opinion of the local clinician/researcher, would preclude participation and successful completion of the protocol, or that would negatively impact or mitigate participation in and completion of the protocol.

Sites / Locations

  • Turku PET CentreRecruiting

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm Type

Experimental

Other

Other

Arm Label

Cold acclimation protocol

Acute cold exposure - control volunteers with obesity

Acute cold exposure - lean controls

Arm Description

Participants with obesity (n = 20) will undergo weekly cold water immersions (water temperature 18ºC, two to three times a week, 30 minutes per day) for, at least, 12 weeks. Before and after the cold acclimation period, the participants will undergo PET/CT scans at room temperature and after controlled cold exposure to investigate BAT perfusion, BAT glucose and NEFA uptakes.

PET/CT scans will be carried out after 2 hours of cold exposure The participants in this group (n = 10) will undergo PET/CT scans at baseline and 12 weeks after the first scan. The participants will undergo PET/CT scans at room temperature and after 2 hours of controlled cold exposure to investigate BAT perfusion, BAT glucose and NEFA uptakes.

PET/CT scans will be carried out after 2 hours of cold exposure The participants in this group (lean, n = 15) will undergo PET/CT scans at room temperature and after 2 hours of controlled cold exposure to investigate BAT perfusion, BAT glucose and NEFA uptakes.

Outcomes

Primary Outcome Measures

Brown adipose tissue perfusion
BAT perfusion will be measured using 15O-O2 and 15O-H2O PET-CT, at room temperature and after 2 hours of cold exposure.

Secondary Outcome Measures

Brown adipose tissue glucose uptake
BAT glucose uptake will be measured after cold exposure using Fluorodeoxyglucose (18F-FDG).
Brown adipose tissue NEFA uptake
BAT NEFA uptake will be measured at room temperature using [18F]fluoro-6-thia-heptadecanoic acid (18F-FTHA).

Full Information

First Posted
July 19, 2022
Last Updated
August 14, 2023
Sponsor
Turku University Hospital
Collaborators
University of Turku, University of Barcelona, University of Ottawa
search

1. Study Identification

Unique Protocol Identification Number
NCT05468151
Brief Title
Cold Acclimation as a Modulator of Brown Adipose Tissue Function in Adults With Obesity
Acronym
MOTORBAT
Official Title
Cold Acclimation as a Modulator of Brown Adipose Tissue Function in Adults With Obesity
Study Type
Interventional

2. Study Status

Record Verification Date
August 2023
Overall Recruitment Status
Recruiting
Study Start Date
July 25, 2022 (Actual)
Primary Completion Date
July 1, 2024 (Anticipated)
Study Completion Date
September 1, 2025 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Turku University Hospital
Collaborators
University of Turku, University of Barcelona, University of Ottawa

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No

5. Study Description

Brief Summary
This study will investigate the effects of at least 12 weeks of weekly cold water immersions (water temperature 18ºC) on BAT perfusion in individuals with obesity. BAT oxygen uptake and tissue perfusion will be measured using 15O-O2 and 15O-H2O PET-CT, at room temperature and after cold exposure. In addition, BAT glucose uptake will be measured using 18F-FDG after 2 hours of cold exposure and BAT NEFA uptake will be analyzed using 18F-FTHA at room temperature. To understrand the metabolic effects of BAT activation in individuals with obesity and how the cold water immersions affect the BAT perfusion in humans is critical for the development of new strategies to treat obesity and its comorbidities.
Detailed Description
Obesity is a highly prevalent non-communicable disease that effects more than 20% of the population worldwide. Brown adipose tissue (BAT) has an unique ability to dissipate the energy as heat and it has been associated with metabolic benefits. Additionally, BAT has been found to be more active in young, healthy, lean individuals and to be inactive in subjects with obesity. Some studies have shown that repeated cold acclimation can enhance BAT metabolism, which is accompanied by metabolic benefits, such as improvements in insulin sensitivity. In this study we will investigate whether 12 weeks or more of cold acclimation are sufficient to improve BAT perfusion at room temperature and after 2 hours of cold exposure, and to stimulate glucose uptake (measured using 18F-FDG) in BAT after 2 hours of cold exposure. Furthermore, changes in BAT NEFA uptake will be analyzed using 18F-FTHA at room temperature. The metabolic effects of the cold acclimation protocol will be evaluated by changes in classical cardiovascular risk markers (lipid profile, glucose and insulin) after 12 weeks. Two different control groups will be included: one will include lean, healthy participants while the other will include subjects with obesity. Both groups will undergo the BAT PET/scans protocol at room temperature and after cold exposure to investigate BAT perfusion, BAT glucose uptake and BAT NEFA uptake. The volunteers with obesity will also undergo a second evaluation 12 weeks after baseline measurements.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Obesity

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
45 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Cold acclimation protocol
Arm Type
Experimental
Arm Description
Participants with obesity (n = 20) will undergo weekly cold water immersions (water temperature 18ºC, two to three times a week, 30 minutes per day) for, at least, 12 weeks. Before and after the cold acclimation period, the participants will undergo PET/CT scans at room temperature and after controlled cold exposure to investigate BAT perfusion, BAT glucose and NEFA uptakes.
Arm Title
Acute cold exposure - control volunteers with obesity
Arm Type
Other
Arm Description
PET/CT scans will be carried out after 2 hours of cold exposure The participants in this group (n = 10) will undergo PET/CT scans at baseline and 12 weeks after the first scan. The participants will undergo PET/CT scans at room temperature and after 2 hours of controlled cold exposure to investigate BAT perfusion, BAT glucose and NEFA uptakes.
Arm Title
Acute cold exposure - lean controls
Arm Type
Other
Arm Description
PET/CT scans will be carried out after 2 hours of cold exposure The participants in this group (lean, n = 15) will undergo PET/CT scans at room temperature and after 2 hours of controlled cold exposure to investigate BAT perfusion, BAT glucose and NEFA uptakes.
Intervention Type
Other
Intervention Name(s)
Cold acclimation
Other Intervention Name(s)
Cold immersion
Intervention Description
The cold water immersions will last 30-60 minutes per day and the volunteers will undergo 2-3 cold immersions per week.
Intervention Type
Other
Intervention Name(s)
Intervention Control group - volunteers with obesity
Intervention Description
Participants with obesity in the control group will undergo PET/CT scans at baseline and 12 weeks after the first scan.
Intervention Type
Other
Intervention Name(s)
Acute cold exposure
Intervention Description
All participants (lean and with obesity) will undergo PET/scans after 2 hours of cold exposure to investigate BAT perfusion and BAT glucose uptake.
Primary Outcome Measure Information:
Title
Brown adipose tissue perfusion
Description
BAT perfusion will be measured using 15O-O2 and 15O-H2O PET-CT, at room temperature and after 2 hours of cold exposure.
Time Frame
After at least 12 weeks of cold acclimation
Secondary Outcome Measure Information:
Title
Brown adipose tissue glucose uptake
Description
BAT glucose uptake will be measured after cold exposure using Fluorodeoxyglucose (18F-FDG).
Time Frame
After at least 12 weeks of cold acclimation
Title
Brown adipose tissue NEFA uptake
Description
BAT NEFA uptake will be measured at room temperature using [18F]fluoro-6-thia-heptadecanoic acid (18F-FTHA).
Time Frame
After at least 12 weeks of cold acclimation
Other Pre-specified Outcome Measures:
Title
Metabolic parameters
Description
Investigate the effects of cold acclimation on blood lipids (total, LDL and HDL cholesterol and triglycerides), fasting glucose and insulin.
Time Frame
After at least 12 weeks of cold acclimation
Title
Energy expenditure
Description
To investigate the effects of cold acclimation on energy expenditure in fasting and postprandial states (after the intake of a mixed meal) using indirect calorimetry
Time Frame
After at least 12 weeks of cold acclimation
Title
BAT gene expression
Description
BAT biopsies will be collected to investigate the effects of cold acclimation on BAT gene expression.
Time Frame
After at least 12 weeks of cold acclimation

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
45 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: BMI>30kg/m2 (for participants with obesity) BMI<25kg/m2 (for lean participants) Waist circumference >94 cm for men (for participants with obesity) Waist circumference > 80 for women (for participants with obesity) Glucose ≥7.8 and <11 mmol/L after OGTT (for participants with obesity) Exclusion Criteria: Being regularly exposed to cold environments for the last 3 months (e.g. having a job as a ski monitor, fishmonger, woodcutter, etc.; or doing sports/leisure activities outdoors for prolonged periods of time, etc.) Having gone for winter/ice swimming and bathing more than once every 2 weeks during the last 3 months. Inability to undergo scanning (e.g., claustrophobia) Pregnancy Smoking (or use of nicotine based products) Hypo/hyperthyroidism Malignancies Immune disorders Viral or bacterial infections Abnormal cardiovascular status, arrhythmia and/or long QTc in ECG, abnormal cardiac murmur, previous history of cardiovascular disease Allergy to lidocaine or epinephrine, or other local anaesthetics Weight change (intentional or not) over the last 6-months > than 5% of body weight Any other cardiovascular, pulmonary, orthopaedic, neurologic, psychiatric or other conditions that in the opinion of the local clinician/researcher, would preclude participation and successful completion of the protocol, or that would negatively impact or mitigate participation in and completion of the protocol.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Kirsi A Virtanen, Prof.
Phone
+358407626564
Email
kianvi@utu.fi
First Name & Middle Initial & Last Name or Official Title & Degree
Sanna Himanen
Phone
+358023135875
Email
sanna.himanen@tyks.fi
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Kirsi A Virtanen
Organizational Affiliation
Turku University Hospital
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Francisco Acosta, PhD
Organizational Affiliation
Turku PET Centre
Official's Role
Study Director
First Name & Middle Initial & Last Name & Degree
Mueez U-Din, PhD
Organizational Affiliation
Turku PET Centre
Official's Role
Study Director
Facility Information:
Facility Name
Turku PET Centre
City
Turku
ZIP/Postal Code
20520
Country
Finland
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Kirsi A Virtanen
Phone
+358407626564
Email
kianvi@utu.fi

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Cold Acclimation as a Modulator of Brown Adipose Tissue Function in Adults With Obesity

We'll reach out to this number within 24 hrs